These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1698216)

  • 21. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice.
    Ludwig GV; Turell MJ; Vogel P; Kondig JP; Kell WK; Smith JF; Pratt WD
    Am J Trop Med Hyg; 2001; 64(1-2):49-55. PubMed ID: 11425162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The immunity generated in white rats vaccinated with strains of the Venezuelan equine encephalomyelitis virus].
    Moshkov SP; Grabareva LP; Moshkov AE; Gaĭdamovich SIa
    Vopr Virusol; 1991; 36(5):417-9. PubMed ID: 1803778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies.
    Mathews JH; Roehrig JT; Trent DW
    J Virol; 1985 Sep; 55(3):594-600. PubMed ID: 2410632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus.
    Yun NE; Peng BH; Bertke AS; Borisevich V; Smith JK; Smith JN; Poussard AL; Salazar M; Judy BM; Zacks MA; Estes DM; Paessler S
    Vaccine; 2009 Jun; 27(30):4064-73. PubMed ID: 19446933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines--III. Kinetics for neutralizing antibody immunoglobulin class responses in donors and adoptively-immunized recipients.
    Rabinowitz SG; Huprikar J; Whitacre C
    Comp Immunol Microbiol Infect Dis; 1979; 1(4):295-303. PubMed ID: 318539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunogenicity of a recombinant strain of vaccinia virus, expressing a Venezuelan equine encephalomyelitis virus structural protein gene in peroral immunization].
    Sviatchenko VA; Kiselev NN; Ryzhikov AB; Bulychev LE; Mikriukova TP; Netesov SV
    Vopr Virusol; 2000; 45(6):38-41. PubMed ID: 11200645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experimental estimation of immunomodulating activity of Tubosan, a new Russian synthetic drug].
    Chernikova NK; Mikhailov VV; Borisevich SV
    Antibiot Khimioter; 2014; 59(9-10):13-6. PubMed ID: 25975110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.
    Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F
    Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of monoclonal antibodies to Venezuelan equine encephalomyelitis virus in specific activation of immunocompetent cells].
    Razumov IA; Razumova TN
    Vopr Virusol; 1995; 40(3):106-9. PubMed ID: 7676669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus.
    Hu WG; Phelps AL; Jager S; Chau D; Hu CC; O'Brien LM; Perkins SD; Gates AJ; Phillpotts RJ; Nagata LP
    Vaccine; 2010 Aug; 28(34):5558-64. PubMed ID: 20600509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
    Rosas CT; Paessler S; Ni H; Osterrieder N
    Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation of single-chain antibody fragments against Venezuelan equine encephalomyelitis virus from two different immune sources.
    Duggan JM; Coates DM; Ulaeto DO
    Viral Immunol; 2001; 14(3):263-73. PubMed ID: 11572636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increase of interleukin-1 beta, gamma interferon and tumor necrosis factor alpha in serum and brain of mice infected with the Venezuelan Equine Encephalitis virus].
    Valerol N; Bonilla E; Espina LM; Maldonado M; Montero E; Añez F; Levy A; Bermudez J; Meleán E; Nery A
    Invest Clin; 2008 Dec; 49(4):457-67. PubMed ID: 19245165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
    Lukin EP; Chernikova NK
    Vopr Virusol; 1993; 38(2):71-4. PubMed ID: 8059525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-factorial specification of virus-host interactions: studies with strains of Venezuelan equine encephalomyelitis virus in mice.
    Walder R; Bradish CJ
    J Gen Virol; 1979 Aug; 44(2):373-82. PubMed ID: 521796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice.
    Schoneboom BA; Catlin KM; Marty AM; Grieder FB
    J Neuroimmunol; 2000 Sep; 109(2):132-46. PubMed ID: 10996215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An attenuated variant of Eastern encephalitis virus: biological properties and protection induced in mice.
    Brown A; Officer JE
    Arch Virol; 1975; 47(2):123-38. PubMed ID: 1119939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.